# Rodo Medical and Straumann Group enter distribution agreement; Straumann increases investment

Rodo Medical and Straumann Group announced that Straumann increased its stake in Rodo Medical from 12% to 30% and obtained exclusive distribution rights for Rodo's Smileloc dental implant retention devices outside North America and South Korea, with an option to increase to 51% in 2021.

- Type: Contract
- Announced: 2017-04-28
- Status: announced
- Products: dental implant retention devices (Smileloc)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Rodo Medical](https://endata.com/companies/23917.md)
- [Straumann Holding AG](https://endata.com/companies/20348.md) (investor)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/rodo-medical-and-straumann-group-enter-into-distribution-agreement-outside-north-america-straumann-increases-its-investment-in-rodo-medical-300446767.html), 2017-04-28: "RODO's ability to develop a revolutionary concept, turn it into a medical device and bring it to market is impressive."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.